Lucira Health.
Privately Held
Lucira Health is commercializing a high selectivity / high sensitivity molecular diagnostic device platform designed for OTC / at-home use. The company’s first product is a completely self-contained molecular diagnostic for SARS-COV-2. A Flu diagnostic is also under development.
Team: Frank Levinson, Zach Jonasson
Website: lucirahealth.com
